Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal function related changes in lithium kinetics.

T R Norman, R G Walker, G D Burrows

    Clinical Pharmacokinetics
    |July 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Acute Kidney Injury: It's not just the 'big' burns.

    Injury·2017
    Same author

    ABO incompatible renal transplantation following lung transplantation.

    Transplant immunology·2016
    Same author

    ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
    Same author

    Relaxation theory and practice.

    The Australian journal of physiotherapy·2014
    Same author

    Relaxation, the physiotherapist and the psychiatric patient.

    The Australian journal of physiotherapy·2014
    Same author

    A multidimensional approach to the assessment of pain.

    The Australian journal of physiotherapy·2014
    Same journal

    Population Pharmacokinetic Modelling of Dolutegravir: A Narrative Review.

    Clinical pharmacokinetics·2026
    Same journal

    Partial Area Under the Curve: A Revelatory Story in Pharmacokinetics.

    Clinical pharmacokinetics·2026
    Same journal

    Informing Sampling Design for Lung Distribution Studies Using a Pulmonary Population Minimal PBPK Model.

    Clinical pharmacokinetics·2026
    Same journal

    Revisited Pharmacokinetic Profiles of Methylprednisolone in Plasma and Urine After Single and Multiple Oral Administrations: Relevance in Sports Drug Testing.

    Clinical pharmacokinetics·2026
    Same journal

    ALBI Grade is a Determinant of Lenvatinib Pharmacokinetics, Efficacy, and Toxicities in Japanese Patients with Hepatocellular Carcinoma.

    Clinical pharmacokinetics·2026
    Same journal

    Quantitative Pharmacology Justifying Ribociclib Dose in Early Breast Cancer.

    Clinical pharmacokinetics·2026
    See all related articles

    Lithium toxicity risk rises with dehydration and sodium loss, especially in older patients with declining kidney function. Reducing lithium dosage in elderly individuals is crucial to prevent adverse effects due to age-related kidney changes.

    Area of Science:

    • Nephrology
    • Pharmacology
    • Geriatrics

    Background:

    • Lithium is a common mood stabilizer, but its narrow therapeutic index necessitates careful monitoring.
    • Renal function significantly impacts lithium clearance and toxicity risk.
    • Age-related changes in kidney function can affect drug metabolism and excretion.

    Purpose of the Study:

    • To investigate the relationship between renal lithium clearance, dehydration, sodium depletion, and age.
    • To examine the correlation between chronic kidney changes, lithium therapy duration, and patient age.
    • To provide recommendations for lithium dosage adjustments in elderly patients.

    Main Methods:

    • Review of physiological factors affecting renal lithium clearance, including dehydration and sodium balance.

    Related Experiment Videos

  • Analysis of histological kidney changes in patients on long-term lithium therapy.
  • Correlation of histological findings with patient age and duration of lithium treatment.

    • Main Results:

    • Renal lithium clearance decreases during dehydration and sodium depletion, increasing toxicity risk.
    • Progressively declining urinary concentrating ability in long-term lithium patients poses a special risk.
    • Chronic kidney histological changes linked to lithium therapy correlate with age, not treatment duration.
    • Age-related renal changes, including decreased glomerular filtration rate, further reduce lithium clearance.

    Conclusions:

    • Elderly patients on lithium therapy are at increased risk of toxicity due to age-related decline in renal function.
    • Lithium dosage should be reduced in older individuals to account for decreased renal clearance.
    • Monitoring renal function and hydration status is critical for patients on lithium therapy, particularly the elderly.